George W.  Lemaitre net worth and biography

George Lemaitre Biography and Net Worth

Chairman & CEO of LeMaitre Vascular

George LeMaitre currently serves as chairman and CEO of LeMaitre Vascular Inc. 

LeMaitre Vascular provides devices, implants and services for the treatment of peripheral vascular disease, a disease that affects more than 200 million people worldwide. LeMaitre has been the CEO and served as part of the company’s board of directors since 1992, and as its chairman since 2004. 

In his previous career, LeMaitre worked for Lehman Brothers as an investment banking analyst. He has also spent time at McCown De Leeuw as an associate of the leveraged buyout firm, and at Connecticut National Bank as a credit analyst. 

LeMaitre holds a bachelor’s degree in history from Stanford University and an M.B.A. from the Stanford Graduate School of Business.

What is George W. Lemaitre's net worth?

The estimated net worth of George W. Lemaitre is at least $166.61 million as of July 12th, 2024. Mr. Lemaitre owns 1,985,358 shares of LeMaitre Vascular stock worth more than $166,611,243 as of March 27th. This net worth estimate does not reflect any other assets that Mr. Lemaitre may own. Learn More about George W. Lemaitre's net worth.

How do I contact George W. Lemaitre?

The corporate mailing address for Mr. Lemaitre and other LeMaitre Vascular executives is 63 SECOND AVENUE, BURLINGTON MA, 01803. LeMaitre Vascular can also be reached via phone at (781) 221-2266. Learn More on George W. Lemaitre's contact information.

Has George W. Lemaitre been buying or selling shares of LeMaitre Vascular?

George W. Lemaitre has not been actively trading shares of LeMaitre Vascular within the last three months. Most recently, George W. Lemaitre sold 27,030 shares of the business's stock in a transaction on Monday, July 15th. The shares were sold at an average price of $86.27, for a transaction totalling $2,331,878.10. Following the completion of the sale, the chief executive officer now directly owns 1,958,328 shares of the company's stock, valued at $168,944,956.56. Learn More on George W. Lemaitre's trading history.

Who are LeMaitre Vascular's active insiders?

LeMaitre Vascular's insider roster includes Lawrence Jasinski (Director), Trent Kamke (Senior Vice President, Operations), George Lemaitre (Chairman & CEO), Joseph Pellegrino, Jr. (CFO), David Roberts (Director), Bridget Ross (Director), and John Roush (Director). Learn More on LeMaitre Vascular's active insiders.

Are insiders buying or selling shares of LeMaitre Vascular?

In the last twelve months, insiders at the medical instruments supplier sold shares 10 times. They sold a total of 136,441 shares worth more than $10,888,005.35. The most recent insider tranaction occured on March, 12th when insider Trent G Kamke sold 2,009 shares worth more than $164,979.08. Insiders at LeMaitre Vascular own 10.8% of the company. Learn More about insider trades at LeMaitre Vascular.

Information on this page was last updated on 3/12/2025.

George W. Lemaitre Insider Trading History at LeMaitre Vascular

George W. Lemaitre Buying and Selling Activity at LeMaitre Vascular

This chart shows George W Lemaitre's buying and selling at LeMaitre Vascular by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal Insider BuyingTotal Insider Selling

LeMaitre Vascular Company Overview

LeMaitre Vascular logo
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Read More

Today's Range

Now: $83.92
Low: $83.74
High: $85.50

50 Day Range

MA: $93.39
Low: $78.82
High: $104.00

2 Week Range

Now: $83.92
Low: $62.39
High: $109.58

Volume

97,898 shs

Average Volume

147,860 shs

Market Capitalization

$1.89 billion

P/E Ratio

45.86

Dividend Yield

0.93%

Beta

0.89